News

Treatment with cibinetide (ARA 290) was shown to promote significant corneal nerve and improve pain and functional capacity in a clinical trial with sarcoidosis patients. The trial was conducted by Araim Pharmaceuticals. Results of the trial were published in the journal Investigative Ophthalmology & Visual Science, in an…

A single mother from the American Midwest with sarcoidosis has started a crowdfunding campaign on the GoFundMe platform to move to a warmer climate to improve her life. The campaign has been described as one of GoFundMe’s most important and life-changing of 2017. Stephanie Jordan of Calumet City, Illinois,…

Sarcoidosis patients are more susceptible to hospitalization than the general population, especially female patients, according to results of a new study. More studies are warranted to understand the reasons why women with sarcoidosis seem to be particularly disposed to hospitalization. The study, “Hospitalization Among Patients With Sarcoidosis: A Population-Based Cohort…

A case was recently reported of a 27-year-old woman who presented ocular pain and moderate vision impairment as the first symptoms of sarcoidosis. Clinicians from the University of Ottawa in Canada reported the case study in the Canadian Medical Association Journal. Sarcoidosis is an inflammatory chronic disease that can…

Cell-based therapies for a variety of lung diseases can be considered safe, according to an analysis that pooled data from all available clinical trials of stem cell therapies. Although death rates were lower in treated patients compared to controls, findings did not indicate any statistically significant differences in either the…

Use of high-resolution computed tomography (HRCT) imaging technique can help identify features of thoracic sarcoidosis, researchers in India report. Because of its superior imaging capacity, they said, this method may allow clinicians to identify subtle chest abnormalities commonly undetectable by standard methods. The results were published in the study “…

Treatment with repository corticotropin (RCI), such as Acthar Gel, may protect the lungs from prednisone-induced damage and improve the outcome in patients with symptomatic pulmonary sarcoidosis, according to results of a clinical trial (NCT02188017). The findings, “Repository Corticotropin For Chronic Pulmonary Sarcoidosis.” were published in the journal Lung.

Loyola Medicine has just performed its 900th transplant, reaching a new milestone in its lung transplant program for patients with conditions affecting the lungs like sarcoidosis. Loyola has outperformed all other transplant centers in Illinois, with three times as many transplants as all the remaining centers combined. In 1988 the…

During Rare Disease Week 2017 on Capitol Hill, the nonprofit Foundation for Sarcoidosis Research (FSR) co-cohosted a briefing to members of Congress stressing the importance of National Sarcoidosis Awareness Month in April. The FSR says recognizing the month would draw more attention to, enhance awareness of, and promote more…

The third annual national awareness campaign “Seek Answers. Inspire Results” aims to bring attention to patients with sarcoidosis. The campaign, a collaboration between the CHEST Foundation and the Foundation of Sarcoidosis Research (FSR), is set to coincide with the National Sarcoidosis Awareness Month in April. Although sarcoidosis is a treatable condition…